{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:30:38Z","timestamp":1773379838783,"version":"3.50.1"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Cutaneous manifestations of multiple myeloma are rare but, as with other extramedullary manifestations, carry a worse prognosis. We present the case of a 65-year-old man with immunoglobulin G \u03ba multiple myeloma and prior autologous stem cell transplant. On subsequent therapy, he presented with multiple new cutaneous and subcutaneous left hip masses. Biopsy of these lesions revealed plasma cell neoplasm with anaplastic morphology, confirming progression of disease. He subsequently underwent radiation to these lesions with plans for chimeric antigen receptor T-cell therapy due to refractory disease.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005579","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T06:00:18Z","timestamp":1732600818000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["18F-FDG PET\/CT Imaging of Cutaneous and Intramuscular Multiple Myeloma"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6772-8395","authenticated-orcid":false,"given":"Brandon","family":"Lippold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin H.","family":"Jahromi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"key":"bib1-20250107","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.3324\/haematol.2012.065698","article-title":"Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents","volume":"97","year":"2012","journal-title":"Haematologica"},{"key":"bib2-20250107","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/RLU.0000000000003179","article-title":"Extramedullary myeloma of the uterus on 18F-FDG PET\/CT: a rare manifestation of multiple myeloma","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib3-20250107","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4274\/tjh.galenos.2020.2020.0134","article-title":"A rare extramedullary presentation of multiple myeloma: paraspinal muscle involvement revealed by FDG PET\/CT","volume":"38","year":"2021","journal-title":"Turk J Haematol"},{"key":"bib4-20250107","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1097\/RLU.0000000000004043","article-title":"Bilateral testicular mass presenting as a rare manifestation of extramedullary plasmacytoma on 18F-FDG PET\/CT","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib5-20250107","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41408-022-00643-3","article-title":"Extramedullary disease in multiple myeloma: a systematic literature review","volume":"12","year":"2022","journal-title":"Blood Cancer J"},{"key":"bib6-20250107","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.3109\/10428194.2015.1128542","article-title":"Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients","volume":"57","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"bib7-20250107","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1067\/mjd.2003.180","article-title":"The spectrum of cutaneous disease in multiple myeloma","volume":"48","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"bib8-20250107","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2214\/AJR.18.20989","article-title":"Comparison of whole-body DWI and (18)F-FDG PET\/CT for detecting intramedullary and extramedullary lesions in multiple myeloma","volume":"213","year":"2019","journal-title":"AJR Am J Roentgenol"},{"key":"bib9-20250107","doi-asserted-by":"crossref","first-page":"1533033819849067","DOI":"10.1177\/1533033819849067","article-title":"Correlation between uptake of (18)F-FDG during PET\/CT and Ki-67 expression in patients newly diagnosed with multiple myeloma having extramedullary involvement","volume":"18","year":"2019","journal-title":"Technol Cancer Res Treat"},{"key":"bib10-20250107","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1097\/RLU.0000000000000902","article-title":"Role of FDG-PET\/CT in extramedullary multiple myeloma: correlation of FDG-PET\/CT findings with clinical outcome","volume":"41","year":"2016","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005579","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:57Z","timestamp":1736294457000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":10,"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005579","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,26]]}}}